157 related articles for article (PubMed ID: 37543580)
1. Association between hospital competition and quality of prostate cancer care.
Jayadevappa R; Malkowicz SB; Vapiwala N; Guzzo TJ; Chhatre S
BMC Health Serv Res; 2023 Aug; 23(1):828. PubMed ID: 37543580
[TBL] [Abstract][Full Text] [Related]
2. Continuity of care and advanced prostate cancer.
Jayadevappa R; Guzzo T; Vapiwala N; Malkowicz SB; Gallo JJ; Chhatre S
Cancer Med; 2023 May; 12(10):11795-11805. PubMed ID: 36951508
[TBL] [Abstract][Full Text] [Related]
3. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
5. Variation in quality of care among older men with localized prostate cancer.
Jayadevappa R; Chhatre S; Johnson JC; Malkowicz SB
Cancer; 2011 Jun; 117(11):2520-9. PubMed ID: 24048800
[TBL] [Abstract][Full Text] [Related]
6. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
Leapman MS; Dinan M; Pasha S; Long J; Washington SL; Ma X; Gross CP
JAMA Oncol; 2022 May; 8(5):687-696. PubMed ID: 35238879
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE).
Chhatre S; Bruce Malkowicz S; Sanford Schwartz J; Jayadevappa R
Medicine (Baltimore); 2015 Aug; 94(32):e1353. PubMed ID: 26266389
[TBL] [Abstract][Full Text] [Related]
8. Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer.
Nyame YA; Holt SK; Etzioni RD; Gore JL
Cancer; 2023 May; 129(9):1402-1410. PubMed ID: 36776124
[TBL] [Abstract][Full Text] [Related]
9. Continuity of care in acute survivorship phase, and short and long-term outcomes in prostate cancer patients.
Chhatre S; Malkowicz SB; Jayadevappa R
Prostate; 2021 Dec; 81(16):1310-1319. PubMed ID: 34516667
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in urologist visits among elderly men with prostate cancer: a cohort analysis of patient-related and county of residence-related factors.
Onukwugha E; Osteen P; Jayasekera J; Mullins CD; Mair CA; Hussain A
Cancer; 2014 Nov; 120(21):3385-92. PubMed ID: 24962590
[TBL] [Abstract][Full Text] [Related]
11. Racial Disparities in End-of-Life Care Among Patients With Prostate Cancer: A Population-Based Study.
Abdollah F; Sammon JD; Majumder K; Reznor G; Gandaglia G; Sood A; Hevelone N; Kibel AS; Nguyen PL; Choueiri TK; Selvaggi KJ; Menon M; Trinh QD
J Natl Compr Canc Netw; 2015 Sep; 13(9):1131-8. PubMed ID: 26358797
[TBL] [Abstract][Full Text] [Related]
12. Income inequality and treatment of African American men with high-risk prostate cancer.
Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
[TBL] [Abstract][Full Text] [Related]
13. Physician visits and the timing of skeletal-related events among men newly diagnosed with metastatic prostate cancer: A cohort analysis.
Onukwugha E; Albarmawi H; Sun K; Mullins CD; Aly A; Hussain A
Urol Oncol; 2018 Jul; 36(7):340.e23-340.e31. PubMed ID: 29724482
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.
Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Saad F; Chun FK; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
Int J Urol; 2018 Nov; 25(11):929-936. PubMed ID: 30146729
[TBL] [Abstract][Full Text] [Related]
15. Lay navigation across the cancer continuum for older cancer survivors: Equally beneficial for Black and White survivors?
Pisu M; Rocque GB; Jackson BE; Kenzik KM; Sharma P; Williams CP; Kvale EA; Taylor RA; Williams GR; Azuero A; Li Y; Acemgil A; Martin MY; Demark-Wahnefried W; Turkman Y; Fouad M; Rocconi RP; Sullivan M; Cantuaria G; Partridge EE; Meneses K
J Geriatr Oncol; 2019 Sep; 10(5):779-786. PubMed ID: 30389494
[TBL] [Abstract][Full Text] [Related]
16. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status.
Vijayakumar S; Weichselbaum R; Vaida F; Dale W; Hellman S
Cancer J Sci Am; 1996; 2(4):225-33. PubMed ID: 9166537
[TBL] [Abstract][Full Text] [Related]
18. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
[TBL] [Abstract][Full Text] [Related]
19. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
Godley PA; Schenck AP; Amamoo MA; Schoenbach VJ; Peacock S; Manning M; Symons M; Talcott JA
J Natl Cancer Inst; 2003 Nov; 95(22):1702-10. PubMed ID: 14625261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
